Evidence map›Paper›PMID 41223198›Full record

ArticlePloS one2025

Predicting the risk of asthma development in youth using machine learning models.

Matthew Xie, Chenliang Xu

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthew XiePittsford Sutherland High School, Pittsford, New York, United States of America.ORCID https://orcid.org/0009-0007-4412-9921
Chenliang XuDepartment of Computer Science, University of Rochester, Rochester, New York, United States of America.ORCID https://orcid.org/0000-0002-2183-822X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a chronic respiratory disease characterized by wheezing and difficulty breathing, which disproportionally affects 4.7 million children in the U.S. Currently, there is a lack of asthma predictive models for youth with good performance. This study aims to build machine learning models to better predict asthma development in youth using easily accessible national survey data. We analyzed cross-sectional combined 2021 and 2022 National Health Interview Survey (NHIS) data from 9,716 youth subjects with their corresponding parent information. We built several machine learning models with various sampling techniques (under- or over-sampling) for asthma prediction in youth, including XGBoost, Neural Networks, Random Forest, Support Vector Machine (SVM), and Logistic Regression. These models were further validated using the 2023 NHIS data. We examined the associations of potential risk factors identified from both Random Forest and Least Absolute Shrinkage and Selection Operator (LASSO) with asthma in youth. Between the different sampling techniques, undersampling the major class (subjects without asthma) yielded the best results in terms of the area under the curve (AUC) and F1 scores for the different predictive models. The Logistic Regression performed the best with the under-sampled data, yielding an AUC score of 0.7654 and an F1 score of 0.3452. Beside of some well-known risk factors for asthma development, such as gender and socioeconomic status, we have identified additional potential factors associated with asthma development in youth such as "took prescription medication in past 12 months", "age" and "general health status" which had the highest magnitude mean Shapley Additive exPlanations (SHAP) values of 0.094, 0.076 and 0.042. This study successfully built machine learning models to predict asthma development in youth with good model performance. This will be important for early screening and detection of asthma in youth.

Indexed as

AsthmaMachine LearningAdolescentChildCross-Sectional StudiesFemaleHumansLogistic ModelsMaleRisk FactorsSupport Vector Machine

Identifiers

PMID41223198
PMCPMC12611137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.